{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:39:08Z","timestamp":1763141948611,"version":"3.41.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 41-year-old woman with invasive lobular carcinoma of the breast underwent sequential <jats:sup>68<\/jats:sup>Ga-PSMA-11 PET\/CT and <jats:sup>18<\/jats:sup>F-fluciclovine PET\/CT as part of an ongoing clinical trial (NCT04750473). <jats:sup>68<\/jats:sup>Ga-PSMA PET\/CT showed increased radiotracer uptake in the uterine endometrium and left adnexa. <jats:sup>18<\/jats:sup>F-fluciclovine PET\/CT showed increased radiotracer uptake in a leiomyomatous uterus. A clinical <jats:sup>18<\/jats:sup>F-FDG PET\/CT demonstrated radiotracer uptake in the endometrium and a circumferential area of uptake in the left adnexa, a pattern more similar to the <jats:sup>68<\/jats:sup>Ga-PSMA uptake pattern. This case highlights the discordance in the uptake pattern of 2 radiotracers approved for prostate cancer imaging but increasingly used in non-prostate malignancies imaging.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004385","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T16:07:47Z","timestamp":1670256467000},"page":"e26-e27","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A Tale of 3 Tracers"],"prefix":"10.1097","volume":"48","author":[{"given":"Ismaheel O.","family":"Lawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omotayo Atinuke","family":"Adediran","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saima","family":"Muzahir","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Friend","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manali Ajay","family":"Bhave","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Meisel","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mylin A.","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toncred Marya","family":"Styblo","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Holbrook","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Kalinsky","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Fielder","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Crowe","sequence":"additional","affiliation":[{"name":"Emory Centre for Systems Imaging Core, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary A.","family":"Ulaner","sequence":"additional","affiliation":[{"name":"Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Schuster","sequence":"additional","affiliation":[{"name":"Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(21)00581-X","article-title":"18F-fluciclovine-PET\/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2\/3 randomised controlled trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1097\/RLU.0000000000003347","article-title":"Oligodendroglioma in 68Ga-PSMA-11 and 18F-fluciclovine PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41416-021-01623-3","article-title":"Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET\/CT imaging","volume":"126","year":"2022","journal-title":"Br J Cancer"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s00259-017-3922-y","article-title":"Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/apm.12504","article-title":"Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study","volume":"124","year":"2016","journal-title":"APMIS"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/01.rlu.0000247261.82757.ea","article-title":"Endometrial and ovarian F-18 FDG uptake in serial PET studies and the value of delayed imaging for differentiation","volume":"31","year":"2006","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","first-page":"266","article-title":"Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET\/CT","volume":"45","year":"2004","journal-title":"J Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2967\/jnumed.114.143628","article-title":"Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease","volume":"55","year":"2014","journal-title":"J Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1097\/RLU.0000000000004013","article-title":"Increased uptake of 18F-PSMA-1007 in corpus luteum demonstrated by PET\/CT","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1097\/RLU.0000000000004258","article-title":"PET imaging of estrogen receptors for gynecological tumors","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.nucmedbio.2006.12.003","article-title":"In vivo imaging of estrogen receptor concentration in the endometrium and myometrium using FES PET\u2014influence of menstrual cycle and endogenous estrogen level","volume":"34","year":"2007","journal-title":"Nucl Med Biol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:02:49Z","timestamp":1750536169000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004385"}},"subtitle":["Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa"],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004385","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,9,6]]}}}